The Entero Healthcare Solutions IPO is a main-board initial public offering (IPO) of 12,718,600 equity shares with a face value of ₹10 each, aggregating up to ₹1,600.00 Crores.
This healthcare products distributor mobilized Rs 716.4 crore through its anchor book on February 8, a day before its IPO opening. Here are the key details:
Issue Price Range: ₹1195 to ₹1258 per share.
Minimum Order Quantity: 11 shares.
IPO Opens: February 9, 2024.
IPO Closes: February 13, 2024.
Listing Date: Tentatively set for Friday, February 16, 2024.
Fresh Issue: 7,949,125 shares (aggregating up to ₹1,000.00 Cr).
Offer for Sale: 4,769,475 shares (aggregating up to ₹600.00 Cr).
Employee Discount: ₹119 per share.
Reservation:
QIBs: Not less than 75% of the Net Issue.
Retail Investors: Not more than 10% of the Net Issue.
NII (HNI): Not more than 15% of the Net Issue.
Book Running Lead Managers: ICICI Securities Limited, Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd), Jefferies India Private Limited, JM Financial Limited, and SBI Capital Markets Limited.
Registrar: Link Intime India Private Ltd.
For retail investors, the minimum investment amount required is ₹13,838. The IPO aims to provide healthcare products distributor Entero Healthcare Solutions with the necessary capital for growth and expansion.
Entero Healthcare Solutions is one of India’s largest and fastest-growing healthcare product distribution platforms. Its product base includes pharmaceutical products, nutraceuticals, medical devices and consumables, vaccines, orthopedic implants, coronary stents, private label products, etc.
Subscribe to Zinkpot Capital on YouTube for videos and more such content. Click here
Comments
Write Comment